All News

"The rate of the foetal heart is subject to considerable variations which affords us a fairly reliable means of judging as to the well-being of the child." This was excerpted from Dr. J. Whitridge Williams, in the second edition of Williams Obstetrics, in 1908.

This article is dedicated to our teacher in gynaecological laparoscopy and dear friend who died after a long illness on July 16th, 2003.

Are these symptoms of Menopause?Am I experiencing Perimenopause?What should I expect from HRT?

Are irregular periods or headaches normal with Premphase?

Many of the most significant changes in maternity-related care have been driven by women (for example, natural childbirth, dads in the delivery room, changing the "drive-through delivery" policy). Fortunately, a growing number of obstetrical specialists (perinatologists) do not accept that a premature baby is "God's will" or just "nature taking its course".

Millions of couples who otherwise would not have been able to conceive children have benefited from advances in fertility treatment. But technological advances, improved access to fertility care as well as a growing demand from infertile couples have resulted in a global growth in the number of multiple births.

These Guidelines have been created through my own experiences with Chronic, Severe pain. Through many trials and errors, I have come up with a few ways of learning to deal and cope with chronic, unbearable pain and how to learn to adapt with the things it effects, in our life in general.

ExAblate 2000 offers women the only non-invasive option for treatment of symptomatic uterine fibroids

Howard I. Glazer, Ph. D., is a clinical associate professor of psychology in Obstetrics and Gynecology at Cornell University Medical College, and an associate attending psychologist at New York Hospital. He specializes in the use of surface electromyographic biofeedback in the treatment of vulvovaginal pain.

Vulvodynia is defined as chronic vulvar discomfort with a duration of at least three months. This discomfort can be expressed as pain, burning, itching, dyspareunia (painful sexual intercourse), stinging, rawness, or "irritation" of a constant or intermittent nature.

Reuse of Electronic Medical Record Data from 189 PatientsVisiting a Swedish University Hospital Emergency Department

Doctor, Are these symptoms of Menopause?Doctor, am I experiencing Perimenopause?Doctor, What should I expect from HRT?

I would be so grateful for your perspective on my annoying chronic pelvic pain. I am 28 years old and in the past decade I have had an array of 'interesting problems: endometriosis, polycystic ovaries, vulvodynia and the popular irritable bowel syndrome.

It is in your best health interest to see your gynecologist or primary care physician regarding specific medical problems or concerns.

It is in your best health interest to see your gynecologist or primary care physician regarding specific medical problems or concerns.

It is in your best health interest to see your gynecologist or primary care physician regarding specific medical problems or concerns.

Clinical situations that typically result in litigation and the variation in jury verdicts and awards across the nation.

Reimbursement for the HPV vaccine; Dealing with sales reps; ER coverage

True consent requires an understanding of decisions-and their consequences. With sensitivity, it's possible to respect a patient's autonomy while acknowledging limitations in her mental state.

While most ob/gyns can recite a long list of risk factors for this lethal complication, mounting evidence suggests that maternal hypotension should be taken into account as well.

Will biological warfare revolutionize the battle against gynecologic cancers? Two experts share the latest molecular tactics using "special" agents. Lethal weapons like Herceptin can throw up some roadblocks, even when they can't always destroy a tumor.

Exacerbation of hyperthyroidism in pregnancy is an obstetric emergency. It demands accurate diagnosis and a prompt therapeutic response in order to minimize risk to mother and fetus.

How many times has a patient said, "Oh, by the way, doctor..." just as you're leaving the exam room? This column will help you quickly triage those seemingly offhand yet clinically significant encounters.

Clinical situations that typically result in litigation and the variation in jury verdicts and awards across the nation.

The majority of Americans are in favor of using a newly approved vaccine to prevent human papillomavirus, according to The Wall Street Journal (8/8/2006). About 70% of Americans agree that girls and young women should be encouraged to receive the HPV vaccine to prevent the spread of cervical cancer, while 7% disagreed and 23% were not sure.

Antimicrobial susceptibility patterns of gram-negative rods causing antepartum pyelonephritis have shown little change over the last 15 years. Susceptibility patterns in 1992 to 1993 and 2004 to 2006 were similar, with 51% and 54% (respectively) of the Escherichia coli strains being resistant to ampicillin, according to Roberts and colleagues from Metrohealth Medical Center in Cleveland. However, E coli resistance to trimethoprim-sulfamethoxazole increased from 5% to 20%. No resistance to first-generation cephalosporins was reported. This study confirms that ampicillin is a poor choice for the treatment of antepartum pyelonephritis.

A new, rapid point-of-care test for group B streptococcus colonization (Cepheid GenXpert), was recently evaluated in a multicenter trial and reported at the annual meeting of the Infectious Disease Society for Obstetrics/Gynecology (IDSOG), held in Monterey, Calif. Dr. Rodney Edwards from the University of Florida reported that the sensitivity of the new test was 91% and the specificity was 96%, used in both antepartum and intrapartum clinical settings. Intrapartum tests were performed by Labor and Delivery nurses after a short training session. Using real-time PCR technology, results are usually available in 70 minutes, which should be timely enough to begin antibiotic prophylaxis for those mothers found to be colonized. Costs of the new technology, which has just been approved by the FDA, vary by locality, but average around $40 per specimen run.